$21.7M to Leidos
ELABORATION AND USE OF SYNGENIC PRE-CLINICAL MODELS FOR CANCER DRUG DEVELOPMENT
- Company
- LDOSLeidos
- Recipient name in record
- LEIDOS BIOMEDICAL RESEARCH INC
- Awarded by
- Department of Health and Human Services · National Institutes of Health
- Value
- $21.7M
- Start date
- 16 Sep 2021
- End date
- 21 Aug 2029
- Award ID
- 75N91021F00017
- Source
- View official record on USAspending.gov ↗
The match between the recipient name and the listed company is made by StockRoz and can contain errors.